Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome

European Journal of Endocrinology

Volumn 160, Issue 5, 2009, Pages 855-862

  Mukherjee, Srabani ^a   Shaikh, Nuzhat ^a   Khavale, Sushma ^a   Shinde, Gayatri ^a   Meherji, Pervin ^a   Shah, Nalini ^b   Maitra, Anurupa ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

^b KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; GENOMIC DNA; INSULIN RECEPTOR; THYMINE; INSR PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADOLESCENT; ADULT; ANDROGEN RELEASE; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE SILENCING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; GLUCOSE HOMEOSTASIS; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BODY WEIGHT; CASE CONTROL STUDY; GENETICS; INDIA; METABOLISM; NUCLEOTIDE SEQUENCE; OBESITY; PHYSIOLOGY;

ADOLESCENT; ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENETIC VARIATION; HUMANS; HYPERANDROGENISM; INDIA; INSULIN RESISTANCE; OBESITY; POLYCYSTIC OVARY SYNDROME; RECEPTOR, INSULIN; THINNESS; YOUNG ADULT;

EID: 65549096682     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0932     Document Type: Article

References (42)

1. Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Reviews in Molecular Medicine 2008 10 e3.
2. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 1997 18 774-800.
3. Franks S. Polycystic ovary syndrome. New England Journal of Medicine 1995 333 853-861.
4. Azziz R,Woods KS, Reyna R, Key TJ, Knochenhauer ES & Yildiz BO. The prevalence and features of polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism 2004 89 2754-2759.
5. Legro RS, Kunselman AR, DodsonWC & Dunaif A. Prevalence and predictors for risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. Journal of Clinical Endocrinology and Metabolism 1999 84 165-169.
6. Diamanti-Kandarakis E. Insulin resistance in PCOS. Endocrine 2006 30 13-17.
7. Legro RS, Finegood D & Dunaif A. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. Journal of Clinical Endocrinology and Metabolism 2005 90 3236-3242.
8. Wild RA, Grubb B, Hartz A, Van Nort JJ, Bachman W & Bartholomew M. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertility and Sterility 1990 54 255-259.
9. Maitra A, Meherji PK, Desai MP, Gokral JS, Donde UM & Joshi UM. Lipoprotein in androgen excess - a study among Indian women. International Journal of Fertility 1994 39 218-222.
10. Maitra A, Pingle RR, Menon PS, Naik V, Gokral JS & Meherji PK. Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: a study among Indian women. International Journal of Fertility and Women's Medicine 2001 46 271-277.
11. Bjornthorp P. Hyperandrogenicity in women - a prediabetic condition? Journal of Internal Medicine 1993 234 609-613.
12. Lunde O, Magnus P, Sandvik L & Hoglo S. Familial clustering in the polycystic ovarian syndrome. Gynecologic and Obstetric Investigation 1989 28 23-30.
13. Yildiz BO, Yarali H, Oguz H & Bayraktar M. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 2031-2036.
14. Escobar-Morreale HF, Luque-Ramírez M & San Millán JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocrine Reviews 2005 26 251-282.
15. Diamanti-Kandarakis E, Piperi C, Spina J, Argyrakopoulou G, Papanastasiou L, Bergiele A & Panidis D. Polycystic ovary syndrome: the influence of environmental and genetic factors. Hormones 2006 5 17-34.
16. Dunaif A, Xia J, Book CB, Schenker E & Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle, A potential mechanism for insulin resistance in the polycystic ovary syndrome. Journal of Clinical Investigation 1995 96 801-810.
17. Diamanti-Kandarakis E & Papavassiliou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends in Molecular Medicine 2006 12 324-332.
18. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF 3rd, Spielman RS & Dunaif A. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. PNAS 1999 96 8573-8578.
19. Tucci S, Futterweit W, Concepcion ES, Greenberg DA, Villanueva R, Davies TF & Tomer Y. Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus. Journal of Clinical Endocrinology and Metabolism 2001 86 446-449.
20. Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM & Yen SS. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 1992 75 577-583.
21. Talbot J, Bicknell E, Rajkhowa M, Krook A, O'Rahilly S & Clayton RN. Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 1996 81 1979-1983.
22. Krook A, Kumar S, Laing I, Boulton AJ, Wass JA & O'Rahilly S. Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes 1994 43 357-368.
23. Moller DE, Cohen O, Yamaguchi Y, Azziz R, Grigorescu F, Eberle A, Morrow LA, Moses AC & Flier JS. Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes 1994 43 247-255.
24. Panz VR, Ruff P, Joffe BI, Kedda MA & Seftel HC. SSCP analysis of the tyrosine kinase domain of the insulin receptor gene: polymorphisms detected in South African black and white subjects. Human Genetics 1996 7 438-440.
25. Siegel S, Futterweit W, Davies TF, Concepcion ES, Greenberg DA, Villanueva R & Tomer Y. A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with PCOS. Fertility and Sterility 2002 78 1240-1243.
26. Chen ZJ, Shi YH, Zhao YR, Li Y, Tang R, Zhao LX & Chang ZH. Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi 2004 39 582-585.
27. Lee EJ, Yoo KJ, Kim SJ, Lee SH, Cha KY & Baek KH. Single nucleotide polymorphism in exon 17 of the insulin receptor gene is not associated with polycystic ovary syndrome in a Korean population. Fertility and Sterility 2006 86 380-384.
28. Jin L, Zhu XM, Luo Q, Qian Y, Jin F & Huang HF. A novel SNP at exon 17 of INSR is associated with decreased insulin sensitivity in Chinese women with PCOS. Molecular Human Reproduction 2006 12 151-155.
29. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004 19 41-47.
30. Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 1999 84 3666-3672.
31. Clark AF, Marcellus S, deLory B & Bird CE. Plasma testosterone free index: a better indicator of plasma androgen activity? Fertility and Sterility 1975 26 1001-1005.
32. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
33. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G & Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 2000 85 2402-2410.
34. Snehalatha C, Viswanathan V & Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 2003 26 1380-1384.
35. Sikaris KA. The clinical biochemistry of obesity more than skin deep. Heart, Lung and Circulation 2007 16 S45-S50.
36. Allahbadia GN & Merchant R. Polycystic ovary syndrome in the Indian subcontinent. Seminars in Reproductive Medicine 2008 26 22-34.
37. Gambineri A, Pelusi C, Vicennati V, Pagotto U & Pasquali R. Obesity and the polycystic ovary syndrome. International Journal of Obesity and Related Metabolic Disorders 2002 26 883-896.
38. Dunaif A, Segal KR, Futterweit W & Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989 38 1165-1174.
39. Vigil P, Contreras P, Alvarado JL, Godoy A, Salgado AM & Cortés ME. Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome. Human Reproduction 2007 11 2974-2980.
40. Tsilchorozidou T, Overton C & Conway GS. The pathophysiology of polycystic ovary syndrome. Clinical Endocrinology 2004 60 1-17.
41. Morin-Papunen L, Vauhkonen I, Koivunen R, Ruokonen A, Martikainen H & Tapanainen JS. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study. Journal of Clinical Endocrinology and Metabolism 2003 88 148-156.
42. Elbein SC & Sorensen LK. Genetic variation in insulin receptor beta-chain exons among members of familial type 2 (non-insulin-dependent) diabetic pedigrees. Diabetologia 1991 34 742-749.